Valuation: IDEXX Laboratories, Inc.

Market Cap 40.84B 214B 36.29B 33.87B 30.87B 58.22B 3,926B 58.76B 410B 159B 2,007B 153B 150B 6,441B P/E 2026 *
35.1x
P/E 2027 * 31x
Enterprise Value 41.21B 216B 36.61B 34.17B 31.15B 58.74B 3,961B 59.29B 414B 160B 2,025B 155B 151B 6,499B EV / Sales 2026 *
8.73x
EV / Sales 2027 * 7.93x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+1.91%
1 month-6.00%
3 months-0.35%
6 months-7.60%
Current year-28.76%
1 month 522.12
Extreme 522.12
538.1
Current year 521.5
Extreme 521.5
773.97
1 year 521.5
Extreme 521.5
813.6
3 years 438.17
Extreme 438.17
813.6
5 years 336.6
Extreme 336.6
813.6
10 years 225.06
Extreme 225.055
813.6
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+1.91%-.--% - - 40.84B
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average -0.04%-0.86%-10.42%+12.44% 76.69B
Weighted average by Cap. +0.13%-1.30%-16.36%+10.13%

Financials

2026 *2027 *
Net sales 4.72B 24.72B 4.2B 3.92B 3.57B 6.73B 454B 6.79B 47.39B 18.37B 232B 17.73B 17.35B 745B 5.14B 26.91B 4.57B 4.26B 3.89B 7.33B 494B 7.4B 51.59B 19.99B 253B 19.3B 18.88B 811B
Net income 1.18B 6.17B 1.05B 978M 891M 1.68B 113B 1.7B 11.83B 4.58B 57.94B 4.43B 4.33B 186B 1.31B 6.88B 1.17B 1.09B 994M 1.87B 126B 1.89B 13.19B 5.11B 64.61B 4.94B 4.83B 207B
Net Debt 368M 1.93B 327M 305M 278M 525M 35.38B 529M 3.69B 1.43B 18.08B 1.38B 1.35B 58.04B -97.34M -510M -86.49M -80.72M -73.57M -139M -9.36B -140M -977M -379M -4.78B -365M -358M -15.35B
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
518.39USD
Average target price
701.33USD
Spread / Average Target
+35.29%

Quarterly revenue - Rate of surprise